Holdings of WisdomTree BioRevolution Fund
WisdomTree Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 2.7M $ including 2.7M $ in equities, 99.9 %
- Positions
- 80 in 10 countries
- Top ten
- 30.7 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | TWIST BIOSCIENCE CORP | 1,548 | 159.3K $ | 5.95 % |
| 2 | MODERNA INC | 1,584 | 110.9K $ | 4.14 % |
| 3 | Eli Lilly & Co | 91 | 109.1K $ | 4.08 % |
| 4 | Johnson & Johnson | 313 | 79.5K $ | 2.97 % |
| 5 | United Therapeutics Corp | 121 | 65.6K $ | 2.45 % |
| 6 | NATERA INC | 229 | 62.2K $ | 2.32 % |
| 7 | Tempus AI Inc | 1,055 | 61.1K $ | 2.28 % |
| 8 | Immunome Inc | 2,850 | 60.4K $ | 2.26 % |
| 9 | STRUCTURE THERAPEUTICS INC | 1,055 | 56.6K $ | 2.11 % |
| 10 | Stoke Therapeutics Inc | 1,712 | 56K $ | 2.09 % |
| 11 | Beam Therapeutics Inc | 1,628 | 55.9K $ | 2.09 % |
| 12 | Corteva Inc | 629 | 53.3K $ | 1.99 % |
| 13 | Krystal Biotech Inc | 141 | 52.4K $ | 1.96 % |
| 14 | Darling Ingredients Inc | 949 | 51.8K $ | 1.94 % |
| 15 | IONIS PHARMACEUTICALS INC | 627 | 49.7K $ | 1.86 % |
| 16 | AstraZeneca PLC | 258 | 48.9K $ | 1.83 % |
| 17 | 10X Genomics Inc | 1,264 | 48.5K $ | 1.81 % |
| 18 | CRISPR Therapeutics AG | 868 | 47.3K $ | 1.77 % |
| 19 | Roivant Sciences Ltd | 1,310 | 46.4K $ | 1.73 % |
| 20 | Absci Corp | 3,939 | 45.7K $ | 1.71 % |
| 21 | REVOLUTION MEDICINES INC | 241 | 45.1K $ | 1.69 % |
| 22 | Agios Pharmaceuticals Inc | 1,134 | 42.1K $ | 1.57 % |
| 23 | Amgen Inc | 114 | 41.3K $ | 1.54 % |
| 24 | Bayer AG | 741 | 41K $ | 1.53 % |
| 25 | Thermo Fisher Scientific Inc | 81 | 40.6K $ | 1.52 % |
| 26 | Gilead Sciences Inc | 320 | 40.4K $ | 1.51 % |
| 27 | Bunge Global SA | 378 | 40.3K $ | 1.51 % |
| 28 | Arrowhead Pharmaceuticals Inc | 484 | 39.5K $ | 1.47 % |
| 29 | Veracyte Inc | 666 | 39.1K $ | 1.46 % |
| 30 | Biohaven Ltd | 2,473 | 36.8K $ | 1.37 % |
| 31 | Novonesis Novozymes B | 582 | 36.8K $ | 1.37 % |
| 32 | Pfizer Inc | 1,494 | 36K $ | 1.34 % |
| 33 | Vertex Pharmaceuticals Inc | 72 | 35.8K $ | 1.34 % |
| 34 | Novartis AG | 227 | 35.6K $ | 1.33 % |
| 35 | uniQure NV | 713 | 32.8K $ | 1.23 % |
| 36 | Catalyst Pharmaceuticals Inc | 914 | 28.7K $ | 1.07 % |
| 37 | Exelixis Inc | 514 | 28K $ | 1.04 % |
| 38 | Cullinan Therapeutics Inc | 1,532 | 27.9K $ | 1.04 % |
| 39 | Protagonist Therapeutics Inc | 224 | 27.5K $ | 1.03 % |
| 40 | DYNE THERAPEUTICS INC | 1,205 | 26.8K $ | 1.00 % |
| 41 | Celldex Therapeutics Inc | 694 | 25.8K $ | 0.96 % |
| 42 | Editas Medicine Inc | 7,881 | 25.5K $ | 0.95 % |
| 43 | Argenx SE | 27 | 25K $ | 0.94 % |
| 44 | Viking Therapeutics Inc | 639 | 24.9K $ | 0.93 % |
| 45 | REGENXBIO Inc | 2,079 | 24.9K $ | 0.93 % |
| 46 | CG ONCOLOGY INC | 340 | 24.2K $ | 0.90 % |
| 47 | BioNTech SE | 252 | 23.4K $ | 0.88 % |
| 48 | Biogen Inc | 102 | 22K $ | 0.82 % |
| 49 | Allogene Therapeutics Inc | 10,528 | 21.9K $ | 0.82 % |
| 50 | Iovance Biotherapeutics Inc | 4,942 | 20.6K $ | 0.77 % |
| 51 | Danaher Corp | 105 | 20K $ | 0.75 % |
| 52 | Repligen Corp | 142 | 19.4K $ | 0.72 % |
| 53 | Merck & Co Inc | 146 | 18.8K $ | 0.70 % |
| 54 | Sana Biotechnology Inc | 5,156 | 18K $ | 0.67 % |
| 55 | Verbio SE | 520 | 17.7K $ | 0.66 % |
| 56 | Halozyme Therapeutics Inc | 222 | 17.4K $ | 0.65 % |
| 57 | Ultragenyx Pharmaceutical Inc | 479 | 16K $ | 0.60 % |
| 58 | Syensqo SA | 214 | 15.8K $ | 0.59 % |
| 59 | FMC Corp | 1,357 | 15.6K $ | 0.58 % |
| 60 | Insmed Inc | 146 | 15.6K $ | 0.58 % |
| 61 | Green Plains Inc | 1,010 | 15.5K $ | 0.58 % |
| 62 | Arcturus Therapeutics Holdings Inc | 2,185 | 14.7K $ | 0.55 % |
| 63 | Illumina Inc | 82 | 14.4K $ | 0.54 % |
| 64 | Regeneron Pharmaceuticals Inc | 23 | 14.3K $ | 0.54 % |
| 65 | Intellia Therapeutics Inc | 841 | 14.2K $ | 0.53 % |
| 66 | Nufarm Ltd | 7,097 | 13.3K $ | 0.50 % |
| 67 | Bio-Techne Corp | 185 | 13.1K $ | 0.49 % |
| 68 | Bridgebio Pharma Inc | 172 | 12.8K $ | 0.48 % |
| 69 | BioMarin Pharmaceutical Inc | 204 | 11.7K $ | 0.44 % |
| 70 | Genmab A/S | 408 | 11.2K $ | 0.42 % |
| 71 | Oxford Nanopore Technologies PLC | 6,496 | 10.7K $ | 0.40 % |
| 72 | Zoetis Inc | 135 | 9.7K $ | 0.36 % |
| 73 | Genus PLC | 320 | 9.1K $ | 0.34 % |
| 74 | Geron Corp | 6,841 | 8.8K $ | 0.33 % |
| 75 | Tyson Foods Inc | 138 | 7.9K $ | 0.30 % |
| 76 | Rocket Pharmaceuticals Inc | 2,310 | 7.9K $ | 0.30 % |
| 77 | ALNYLAM PHARMACEUTICALS INC | 26 | 7.8K $ | 0.29 % |
| 78 | SAREPTA THERAPEUTICS INC | 419 | 7.5K $ | 0.28 % |
| 79 | Pacific Biosciences of California Inc | 4,222 | 7.1K $ | 0.26 % |
| 80 | QIAGEN NV | 172 | 6.7K $ | 0.25 % |
Sector breakdown
- Health care 35.3 %
- Materials 2.0 %
- Consumer staples 1.8 %
- Unattributed 60.9 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 93.3 %
- EUR 2.8 %
- DKK 1.4 %
- CHF 1.3 %
- GBP 0.7 %
- AUD 0.5 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 83.1 %
- Switzerland 3.1 %
- Germany 3.1 %
- United Kingdom 2.6 %
- Netherlands 2.2 %
- Denmark 1.8 %
- Bermuda 1.7 %
- British Virgin Islands 1.4 %
- Belgium 0.6 %
- Australia 0.5 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 64 | 2.2M $ | 83.09 % |
| 2 | Switzerland | 2 | 83K $ | 3.10 % |
| 3 | Germany | 3 | 82.2K $ | 3.07 % |
| 4 | United Kingdom | 3 | 68.7K $ | 2.57 % |
| 5 | Netherlands | 2 | 57.9K $ | 2.17 % |
| 6 | Denmark | 2 | 48K $ | 1.79 % |
| 7 | Bermuda | 1 | 46.4K $ | 1.73 % |
| 8 | British Virgin Islands | 1 | 36.8K $ | 1.38 % |
| 9 | Belgium | 1 | 15.8K $ | 0.59 % |
| 10 | Australia | 1 | 13.3K $ | 0.50 % |
Cite this page
Titelia. "Holdings of WisdomTree BioRevolution Fund". https://titelia.com/en/funds/S000071961